These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32550894)
1. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Wang S; Zhang F; Yu G; Wang Z; Jacobson O; Ma Y; Tian R; Deng H; Yang W; Chen ZY; Chen X Theranostics; 2020; 10(15):6629-6637. PubMed ID: 32550894 [TBL] [Abstract][Full Text] [Related]
2. Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy. Hao Q; Wang Z; Zhao W; Wen L; Wang W; Lu S; Xing D; Zhan M; Hu X ACS Appl Mater Interfaces; 2020 Nov; 12(44):49489-49501. PubMed ID: 33079514 [TBL] [Abstract][Full Text] [Related]
3. Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy. Wang Y; Cong Y; Cai M; Liang X; Wang L; Zhou D J Control Release; 2023 Apr; 356():567-579. PubMed ID: 36924894 [TBL] [Abstract][Full Text] [Related]
4. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy. Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593 [TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species-activatable camptothecin polyprodrug based dextran enhances chemotherapy efficacy by damaging mitochondria. Zhang T; Ma X; Bai S; Wang Y; Zhang X; Lu Y; Wen F; Xue P; Kang Y; Xu Z J Mater Chem B; 2020 Feb; 8(6):1245-1255. PubMed ID: 31957760 [TBL] [Abstract][Full Text] [Related]
6. "Bottom-up" Construction of Multi-Polyprodrug-Arm Hyperbranched Amphiphiles for Cancer Therapy. Sun P; Chen D; Deng H; Wang N; Huang P; Jin X; Zhu X Bioconjug Chem; 2017 May; 28(5):1470-1480. PubMed ID: 28441015 [TBL] [Abstract][Full Text] [Related]
7. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965 [No Abstract] [Full Text] [Related]
8. Self-Assembled Polyprodrug Amphiphile for Subcutaneous Xenograft Tumor Inhibition with Prolonged Acting Time In Vivo. Chen D; Huang Y; Xu S; Jiang H; Wu J; Jin X; Zhu X Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28737832 [TBL] [Abstract][Full Text] [Related]
9. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery. Hu X; Hu J; Tian J; Ge Z; Zhang G; Luo K; Liu S J Am Chem Soc; 2013 Nov; 135(46):17617-29. PubMed ID: 24160840 [TBL] [Abstract][Full Text] [Related]
10. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy. Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571 [TBL] [Abstract][Full Text] [Related]
12. Glutathione-depleting polyprodrug nanoparticle for enhanced photodynamic therapy and cascaded locoregional chemotherapy. Zhang X; Zhang X; Chen S; Liu Y; Cao C; Cheng G; Wang S J Colloid Interface Sci; 2024 Sep; 670():279-287. PubMed ID: 38763024 [TBL] [Abstract][Full Text] [Related]
13. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication. Liang B; Zhou D Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277 [TBL] [Abstract][Full Text] [Related]
14. Surface-adaptive zwitterionic nanoparticles for prolonged blood circulation time and enhanced cellular uptake in tumor cells. Ou H; Cheng T; Zhang Y; Liu J; Ding Y; Zhen J; Shen W; Xu Y; Yang W; Niu P; Liu J; An Y; Liu Y; Shi L Acta Biomater; 2018 Jan; 65():339-348. PubMed ID: 29079515 [TBL] [Abstract][Full Text] [Related]
15. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846 [TBL] [Abstract][Full Text] [Related]
16. A polyprodrug-based nanoplatform for cisplatin prodrug delivery and combination cancer therapy. Lin C; Tao Y; Saw PE; Cao M; Huang H; Xu X Chem Commun (Camb); 2019 Nov; 55(93):13987-13990. PubMed ID: 31687673 [TBL] [Abstract][Full Text] [Related]
17. Fabrication of Reductive-Responsive Prodrug Nanoparticles with Superior Structural Stability by Polymerization-Induced Self-Assembly and Functional Nanoscopic Platform for Drug Delivery. Zhang WJ; Hong CY; Pan CY Biomacromolecules; 2016 Sep; 17(9):2992-9. PubMed ID: 27548375 [TBL] [Abstract][Full Text] [Related]
18. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine. Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129 [TBL] [Abstract][Full Text] [Related]
19. Smart Unimolecular Micelle-Based Polyprodrug with Dual-Redox Stimuli Response for Tumor Microenvironment: Enhanced in Vivo Delivery Efficiency and Tumor Penetration. Bai S; Ma X; Shi X; Shao J; Zhang T; Wang Y; Cheng Y; Xue P; Kang Y; Xu Z ACS Appl Mater Interfaces; 2019 Oct; 11(39):36130-36140. PubMed ID: 31490659 [TBL] [Abstract][Full Text] [Related]
20. Enhanced Tumor Penetration and Chemotherapy Efficiency by Covalent Self-Assembled Nanomicelle Responsive to Tumor Microenvironment. Ma X; Bai S; Zhang X; Ma X; Jia D; Shi X; Shao J; Xue P; Kang Y; Xu Z Biomacromolecules; 2019 Jul; 20(7):2637-2648. PubMed ID: 31141665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]